Format
Sort by

Send to

Choose Destination

Search results

Items: 16

1.

Molecular basis of aromatase inhibitor associated arthralgia: known and potential candidate genes and associated biomarkers.

Borrie AE, Kim RB.

Expert Opin Drug Metab Toxicol. 2016 Sep 20:1-8. [Epub ahead of print]

PMID:
27635473
2.

Cardiac tamponade: a rare complication of Nissen fundoplication.

Borrie AJ.

ANZ J Surg. 2016 Aug 26. doi: 10.1111/ans.13726. [Epub ahead of print] No abstract available.

PMID:
27565456
3.

Outcomes of surgical ablation for atrial fibrillation: a 10-year experience.

Borrie AJ, Wademan BH.

N Z Med J. 2016 Apr 22;129(1433):17-24.

PMID:
27349157
4.

Cisplatin Nephrotoxicity and Longitudinal Growth in Children With Solid Tumors: A Retrospective Cohort Study.

Jiménez-Triana CA, Castelán-Martínez OD, Rivas-Ruiz R, Jiménez-Méndez R, Medina A, Clark P, Rassekh R, Castañeda-Hernández G, Carleton B, Medeiros M; Canadian Pharmacogenomics Network for Drug Safety Consortium..

Medicine (Baltimore). 2015 Aug;94(34):e1413. doi: 10.1097/MD.0000000000001413.

5.

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer.

Aminkeng F, Bhavsar AP, Visscher H, Rassekh SR, Li Y, Lee JW, Brunham LR, Caron HN, van Dalen EC, Kremer LC, van der Pal HJ, Amstutz U, Rieder MJ, Bernstein D, Carleton BC, Hayden MR, Ross CJ; Canadian Pharmacogenomics Network for Drug Safety Consortium..

Nat Genet. 2015 Sep;47(9):1079-84. doi: 10.1038/ng.3374.

6.

Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children.

Visscher H, Rassekh SR, Sandor GS, Caron HN, van Dalen EC, Kremer LC, van der Pal HJ, Rogers PC, Rieder MJ, Carleton BC, Hayden MR, Ross CJ; CPNDS consortium..

Pharmacogenomics. 2015;16(10):1065-76. doi: 10.2217/pgs.15.61.

PMID:
26230641
7.

HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.

Amstutz U, Ross CJ, Castro-Pastrana LI, Rieder MJ, Shear NH, Hayden MR, Carleton BC; CPNDS Consortium..

Clin Pharmacol Ther. 2013 Jul;94(1):142-9. doi: 10.1038/clpt.2013.55.

8.

Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent.

Aminkeng F, Ross CJ, Rassekh SR, Brunham LR, Sistonen J, Dube MP, Ibrahim M, Nyambo TB, Omar SA, Froment A, Bodo JM, Tishkoff S, Carleton BC, Hayden MR; Canadian Pharmacogenomics Network for Drug Safety Consortium..

Pharmacogenomics J. 2014 Apr;14(2):160-70. doi: 10.1038/tpj.2013.13.

9.

Absence of NR2E1 mutations in patients with aniridia.

Corso-Díaz X, Borrie AE, Bonaguro R, Schuetz JM, Rosenberg T, Jensen H, Brooks BP, Macdonald IM, Pasutto F, Walter MA, Grønskov K, Brooks-Wilson A, Simpson EM.

Mol Vis. 2012;18:2770-82.

10.
11.

Towards the reflective sports coach: issues of context, education and application.

Knowles Z, Borrie A, Telfer H.

Ergonomics. 2005 Sep 15-Nov 15;48(11-14):1711-20.

PMID:
16338735
12.

Temporal pattern analysis and its applicability in sport: an explanation and exemplar data.

Borrie A, Jonsson GK, Magnusson MS.

J Sports Sci. 2002 Oct;20(10):845-52.

PMID:
12363299
13.
14.

Physiology applied to field hockey.

Reilly T, Borrie A.

Sports Med. 1992 Jul;14(1):10-26. Review.

PMID:
1641540
15.

Hugh Alexander Allen Stevely.

Borrie AW.

N Z Med J. 1980 Feb 13;91(653):108-9. No abstract available.

PMID:
6991991
16.

Obituary: Alastair Gordon Gilchrist.

Borrie AW.

N Z Med J. 1977 May 11;85(587):392-3. No abstract available.

PMID:
340998
Items per page

Supplemental Content

Loading ...
Support Center